Cargando…
Genome-wide siRNA screen identifies UNC50 as a regulator of Shiga toxin 2 trafficking
Shiga toxins 1 and 2 (STx1 and STx2) undergo retrograde trafficking to reach the cytosol. Early endosome-to-Golgi transport allows the toxins to evade degradation in lysosomes. Targeting this trafficking step has therapeutic promise, but the mechanism of trafficking for the more potent toxin STx2 is...
Autores principales: | Selyunin, Andrey S., Iles, Lakesla R., Bartholomeusz, Geoffrey, Mukhopadhyay, Somshuvra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5626549/ https://www.ncbi.nlm.nih.gov/pubmed/28883040 http://dx.doi.org/10.1083/jcb.201704015 |
Ejemplares similares
-
Tamoxifen blocks retrograde trafficking of Shiga toxin 1 and 2 and protects against lethal toxicosis
por: Selyunin, Andrey S, et al.
Publicado: (2019) -
Targeting the Early Endosome-to-Golgi Transport of Shiga Toxins as a Therapeutic Strategy
por: Li, Danyang, et al.
Publicado: (2020) -
Tamoxifen Derivatives Alter Retromer-Dependent Endosomal Tubulation and Sorting to Block Retrograde Trafficking of Shiga Toxins
por: Selyunin, Andrey S., et al.
Publicado: (2021) -
Shiga toxin–binding site for host cell receptor GPP130 reveals unexpected divergence in toxin-trafficking mechanisms
por: Mukhopadhyay, Somshuvra, et al.
Publicado: (2013) -
Carbon Nanotubes: Solution for the Therapeutic Delivery of siRNA?
por: Kirkpatrick, D. Lynn, et al.
Publicado: (2012)